高强度聚焦超声消融与子宫肌瘤剔除术治疗子宫肌瘤的生殖结局:系统综述与Meta分析
该系统综述与Meta分析纳入截至2024年3月已发表研究,比较高强度聚焦超声(HIFU)消融与子宫肌瘤剔除术治疗子宫肌瘤后的生殖结局。HIFU的合并妊娠率为23.3%(95%CI 11.5至37.6%),合并活产率为17.3%(95%CI 7.8至29.3%);肌瘤剔除术的合并妊娠率为56.9%(95%CI 45.6至67.9%),合并活产率为44.1%(95%CI 34.9至53.4%),差异有统计学意义(P=0.0001和P=0.0003)。控制患者年龄后,超声引导HIFU研究的妊娠率和活产率仍显著低于肌瘤剔除术。
要点
- HIFU后合并妊娠率23.3%(95%CI 11.5至37.6%),合并活产率17.3%(95%CI 7.8至29.3%)。
- 肌瘤剔除术后合并妊娠率56.9%(95%CI 45.6至67.9%),合并活产率44.1%(95%CI 34.9至53.4%)。
- HIFU的妊娠率与活产率均显著低于肌瘤剔除术(P=0.0001和P=0.0003)。
核心结论
- 有保留子宫意愿的子宫肌瘤患者接受HIFU治疗后,生殖结局较肌瘤剔除术更差。
- HIFU治疗子宫肌瘤的生殖结局研究在设计与实施质量上仍有较大提升空间。
- 亟需开展与标准治疗对照的比较性试验。
研究设计与样本
- 系统综述与Meta分析,检索截至2024年已发表研究的数据。
主要发现
- HIFU的合并妊娠率为23.3%(95%CI 11.5至37.6%),合并活产率为17.3%(95%CI 7.8至29.3%)。
- 肌瘤剔除术的合并妊娠率为56.9%(95%CI 45.6至67.9%),合并活产率为44.1%(95%CI 34.9至53.4%)。
- HIFU与肌瘤剔除术的妊娠率比较P=0.0001,活产率比较P=0.0003,HIFU均显著更低。
- 控制患者年龄后,超声引导HIFU研究的妊娠率和活产率仍显著低于肌瘤剔除术。
- 纳入较年轻患者及明确招募有生育意愿者的研究,报告了更好的生殖结局。
局限性
- HIFU治疗子宫肌瘤生殖结局的研究在设计与实施质量上仍有较大提升空间。
- 亟需开展与标准治疗对照的比较性试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does high-intensity focused ultrasound (HIFU) ablation have comparable reproductive outcomes to myomectomy for patients with uterine fibroids? DESIGN: A systematic review and a meta-analysis of data extracted from published studies up to March 2024. RESULTS: Through a more structured analysis, HIFU treatment yielded a pooled pregnancy rate of 23.3% (95% CI 11.5 to 37.6%) and a pooled live birth rate (LBR) of 17.3% (95% CI 7.8 to 29.3%), significantly lower than those after myomectomy, which had a pooled pregnancy rate of 56.9% (95% CI 45.6 to 67.9%) and a pooled LBR of 44.1% (95% CI 34.9 to 53.4%) (P = 0.0001 and P = 0.0003, respectively). After controlling for patient age, ultrasound-guided HIFU studies reported significantly lower pregnancy rate and LBR compared with myomectomy. Moreover, studies enrolling younger patients and explicitly recruiting those desiring to conceive reported better reproductive outcomes. CONCLUSIONS: Patients with uterine fibroids undergoing HIFU treatment and desiring to preserve their uteri resulted in poorer reproductive outcomes compared with myomectomy. Although uterine fibroids are now the number one disease that receives HIFU treatment worldwide, the overall quality in design and execution of HIFU studies on reproductive outcomes for women with uterine fibroids leaves much room for improvement. Above all, comparative trials against the standard of care are badly needed.
引用
- Chen Y, Yi J, Lin S, et al. Reproductive outcomes of high-intensity focused ultrasound ablation and myomectomy for uterine fibroids: a systematic review and meta-analysis. Reprod Biomed Online. 2024. PMID: 39616958. doi:10.1016/j.rbmo.2024.104436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。